JPY 434.0
(-0.46%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 14.04 Billion JPY | -3.94% |
2022 | 14.62 Billion JPY | 1.75% |
2021 | 14.36 Billion JPY | 15.45% |
2020 | 12.44 Billion JPY | 10.55% |
2019 | 11.25 Billion JPY | 4.62% |
2018 | 10.76 Billion JPY | 41.2% |
2017 | 7.62 Billion JPY | 18.31% |
2016 | 6.44 Billion JPY | -2.08% |
2015 | 6.57 Billion JPY | 0.92% |
2014 | 6.51 Billion JPY | 4.57% |
2013 | 6.23 Billion JPY | -0.24% |
2012 | 6.24 Billion JPY | -3.66% |
2011 | 6.48 Billion JPY | 24.95% |
2010 | 5.19 Billion JPY | 7.15% |
2009 | 4.84 Billion JPY | -0.69% |
2008 | 4.87 Billion JPY | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q2 | 4.04 Billion JPY | 6.59% |
2024 Q3 | 4.08 Billion JPY | 1.0% |
2024 Q1 | 3.79 Billion JPY | -0.88% |
2023 Q3 | 3.71 Billion JPY | -6.19% |
2023 Q2 | 3.96 Billion JPY | 7.7% |
2023 FY | 14.04 Billion JPY | -3.94% |
2023 Q4 | 3.83 Billion JPY | 3.09% |
2023 Q1 | 3.67 Billion JPY | 8.99% |
2022 FY | 14.62 Billion JPY | 1.75% |
2022 Q1 | 3.61 Billion JPY | 0.19% |
2022 Q3 | 3.81 Billion JPY | -0.23% |
2022 Q2 | 3.82 Billion JPY | 5.81% |
2022 Q4 | 3.37 Billion JPY | -11.46% |
2021 FY | 14.36 Billion JPY | 15.45% |
2021 Q2 | 3.72 Billion JPY | 10.98% |
2021 Q1 | 3.35 Billion JPY | 2.1% |
2021 Q3 | 3.68 Billion JPY | -0.98% |
2021 Q4 | 3.6 Billion JPY | -2.23% |
2020 FY | 12.44 Billion JPY | 10.55% |
2020 Q3 | 3.21 Billion JPY | 4.13% |
2020 Q1 | 2.86 Billion JPY | -3.8% |
2020 Q2 | 3.08 Billion JPY | 7.47% |
2020 Q4 | 3.28 Billion JPY | 2.36% |
2019 FY | 11.25 Billion JPY | 4.62% |
2019 Q2 | 2.82 Billion JPY | 6.98% |
2019 Q1 | 2.64 Billion JPY | -5.65% |
2019 Q3 | 2.8 Billion JPY | -0.72% |
2019 Q4 | 2.98 Billion JPY | 6.23% |
2018 Q4 | 2.8 Billion JPY | 4.27% |
2018 FY | 10.76 Billion JPY | 41.2% |
2018 Q2 | 5.26 Billion JPY | 66855.66% |
2018 Q1 | 7.86 Million JPY | 125.73% |
2018 Q3 | 2.68 Billion JPY | -48.99% |
2017 Q4 | -30.57 Million JPY | -101.17% |
2017 FY | 7.62 Billion JPY | 18.31% |
2017 Q3 | 2.62 Billion JPY | -0.73% |
2017 Q2 | 2.64 Billion JPY | 10.53% |
2017 Q1 | 2.38 Billion JPY | 307.55% |
2016 Q1 | 2.42 Billion JPY | 337.24% |
2016 FY | 6.44 Billion JPY | -2.08% |
2016 Q4 | -1.15 Billion JPY | -145.3% |
2016 Q3 | 2.54 Billion JPY | -3.43% |
2016 Q2 | 2.63 Billion JPY | 8.72% |
2015 Q1 | 2.58 Billion JPY | 329.97% |
2015 Q2 | 2.54 Billion JPY | -1.55% |
2015 Q3 | 2.47 Billion JPY | -2.64% |
2015 FY | 6.57 Billion JPY | 0.92% |
2015 Q4 | -1.02 Billion JPY | -141.22% |
2014 Q2 | 2.51 Billion JPY | 5.57% |
2014 Q1 | 2.37 Billion JPY | 320.93% |
2014 FY | 6.51 Billion JPY | 4.57% |
2014 Q4 | -1.12 Billion JPY | -140.77% |
2014 Q3 | 2.75 Billion JPY | 9.73% |
2013 Q3 | 2.42 Billion JPY | 0.89% |
2013 Q4 | -1.07 Billion JPY | -144.41% |
2013 FY | 6.23 Billion JPY | -0.24% |
2013 Q1 | 2.48 Billion JPY | 327.04% |
2013 Q2 | 2.4 Billion JPY | -3.33% |
2012 Q3 | 2.53 Billion JPY | 4.85% |
2012 Q2 | 2.41 Billion JPY | 0.91% |
2012 Q4 | -1.09 Billion JPY | -143.2% |
2012 FY | 6.24 Billion JPY | -3.66% |
2012 Q1 | 2.39 Billion JPY | 404.7% |
2011 Q2 | 2.49 Billion JPY | 8.94% |
2011 FY | 6.48 Billion JPY | 24.95% |
2011 Q1 | 2.28 Billion JPY | 2503.38% |
2011 Q3 | 2.48 Billion JPY | -0.23% |
2011 Q4 | -785.88 Million JPY | -131.58% |
2010 Q1 | 1.66 Billion JPY | 3534.37% |
2010 Q3 | 1.75 Billion JPY | 4.5% |
2010 Q2 | 1.68 Billion JPY | 1.12% |
2010 FY | 5.19 Billion JPY | 7.15% |
2010 Q4 | 87.95 Million JPY | -95.0% |
2009 Q3 | 1.64 Billion JPY | 7.11% |
2009 Q1 | 1.7 Billion JPY | 0.0% |
2009 FY | 4.84 Billion JPY | -0.69% |
2009 Q2 | 1.53 Billion JPY | -10.01% |
2009 Q4 | -48.44 Million JPY | -102.94% |
2008 FY | 4.87 Billion JPY | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
HEARTSEED INC | 1.8 Billion JPY | -678.335% |
Cawachi Limited | 58.2 Billion JPY | 75.87% |
Pharmarise Holdings Corporation | 7.53 Billion JPY | -86.43% |
Qol Holdings Co., Ltd. | 14.92 Billion JPY | 5.911% |
MatsukiyoCocokara & Co. | 278.39 Billion JPY | 94.955% |
Welcia Holdings Co., Ltd. | 326.87 Billion JPY | 95.704% |
Create SD Holdings Co., Ltd. | 85.11 Billion JPY | 83.5% |
NIHON CHOUZAI Co.,Ltd. | 48.09 Billion JPY | 70.799% |
COSMOS Pharmaceutical Corporation | 156.8 Billion JPY | 91.044% |
Tsuruha Holdings Inc. | 263.07 Billion JPY | 94.662% |
Ohki Healthcare Holdings Co.,Ltd. | 14.84 Billion JPY | 5.41% |
Satudora Holdings Co.,Ltd. | 20.92 Billion JPY | 32.885% |
Kusuri No Aoki Holdings Co., Ltd. | 99.52 Billion JPY | 85.889% |
Medical System Network Co., Ltd. | 44.09 Billion JPY | 68.15% |
Shinnihonseiyaku Co., Ltd. | 26.55 Billion JPY | 47.12% |
Sugi Holdings Co.,Ltd. | 192.21 Billion JPY | 92.694% |
YAKUODO HOLDINGS Co., Ltd. | 22.65 Billion JPY | 37.996% |
Genky DrugStores Co., Ltd. | 28.6 Billion JPY | 50.906% |
Ain Holdings Inc. | 39.09 Billion JPY | 64.074% |
Sundrug Co.,Ltd. | 148.32 Billion JPY | 90.532% |